Literature DB >> 7495332

Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022.

U Kohnert1, M Wozny, M Llinas, A Roos, S Fischer.   

Abstract

BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495332     DOI: 10.1007/bf02783556

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  9 in total

1.  Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.

Authors:  B R Binder; J Spragg; K F Austen
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

2.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

3.  The incorporation of a fluorescent probe into the active sites of one- and two-chain tissue-type plasminogen activator.

Authors:  D L Higgins; M C Lamb
Journal:  Arch Biochem Biophys       Date:  1986-09       Impact factor: 4.013

4.  An active-site titrant for human tissue-type plasminogen activator.

Authors:  R A Smith
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

5.  X-ray diffraction studies of enzymes.

Authors:  D M Blow; T A Steitz
Journal:  Annu Rev Biochem       Date:  1970       Impact factor: 23.643

6.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.

Authors:  D Pennica; W E Holmes; W J Kohr; R N Harkins; G A Vehar; C A Ward; W F Bennett; E Yelverton; P H Seeburg; H L Heyneker; D V Goeddel; D Collen
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

7.  Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates.

Authors:  J Stürzebecher; U Neumann; U Kohnert; G B Kresse; S Fischer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

8.  Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.

Authors:  E K Kruithof; W D Schleuning; F Bachmann
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

9.  Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.

Authors:  T Urano; S Urano; F J Castellino
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.